| Entry |
|
| Name |
Acetaminophen (JP16/USP);
Paracetamol (INN);
Tylenol (TN)
|
| Product |
|
| Generic |
|
| Other |
|
| Formula |
C8H9NO2
|
| Exact mass |
151.0633
|
| Mol weight |
151.1626
|
| Structure |

     |
| Activity |
Analgesic;
Antipyretic
|
| Remark |
Same as: Therapeutic category: ATC code: |
| Comment |
Nonsteroidal antiinflammatory drugs (NSAIDs)
|
| Metabolism |
Enzyme: CYP2E1 [HSA: 1571], CYP2A6 [HSA: 1548], CYP3A4 [HSA: 1576], CYP1A2 [HSA: 1544]
|
| Interaction |
Genomic biomarker: CYP2D6 [HSA: 1565]
 |
| Structure map |
| Antimigraines | | Cyclooxygenase inhibitors |
|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
114 Antipyretics and analgesics, anti-inflammatory agents
1141 Anilines
D00217 Acetaminophen (JP16/USP); Paracetamol (INN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N02 ANALGESICS
N02B OTHER ANALGESICS AND ANTIPYRETICS
N02BE Anilides
N02BE01 Paracetamol
D00217 Acetaminophen (JP16/USP); Paracetamol (INN)
 |
| Other DBs |
CAS: 103-90-2 PubChem: DrugBank: PDB-CCD: LigandBox: NIKKAJI: |
| KCF data |
 ATOM 11
1 C8y C 21.1806 -16.6437
2 C8x C 21.1806 -18.0466
3 C8x C 19.9699 -15.9511
4 N1b N 22.3914 -15.9511
5 C8x C 19.9699 -18.7509
6 C8x C 18.7534 -16.6437
7 C5a C 23.6080 -16.6496
8 C8y C 18.7534 -18.0466
9 C1a C 24.8186 -15.9511
10 O5a O 23.6020 -18.0466
11 O1a O 17.5425 -18.7509
BOND 11
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 2
5 3 6 1
6 4 7 1
7 5 8 1
8 7 9 1
9 7 10 2
10 8 11 1
11 6 8 2
|